News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Stock Titan Balance sheet
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
This article provides a brief overview of VSee Health, Inc.'s cash flow, focusing on operating, investing, and financing activities. For Q1 2026, the free cash flow was -$2.48 million USD, while for 2025, it was -$3.48 million USD with operating cash flow at -$3.45 …
This article provides a revenue breakdown for VSee Health, Inc. (OTC:VSEE), highlighting that the United States is the primary contributor to its revenue. In the last year, the U.S. segment generated $14.62 million, an increase from $10.42 million the previous year. The data is …
The article reports on the equity in earnings of VSee Health, Inc. (OTC:VSEE). It provides an overview of the company's financial data as available on TradingView. The content is primarily a listing of navigation and footer elements typical of a financial data platform.
VSee Health, Inc. (OTC:VSEE) reported its Q1 2026 financial position, showing total assets at $19.02 million, a 15.15% decrease from Q4 2025. Total liabilities also decreased by 25.15% to $12.70 million in the same quarter. The report provides a snapshot of the company's balance …
This article provides financial data for VSee Health, Inc. (OTC:VSEE), specifically focusing on its return on assets percentage. It indicates the stock's market status as closed with no recent trades, and presents information about its financial overview on the TradingView platform.
VSee Health is facing suspension and delisting from Nasdaq due to its stock consistently trading below $1.00 and recently falling to $0.10 or less for ten consecutive days. The company, which previously received a 180-day grace period, may request a hearing but cautions that …
VSee Health, Inc. (OTCPK:VSEE) has been removed from the NASDAQ Composite Index as of August 4, 2026. This news follows several recent developments for the company, including signing a letter of intent to acquire certain healthcare technology assets for $42 million and initiating a …
VSee Health received a delisting notice from Nasdaq on July 30, 2026, because its closing bid price fell below $0.10 for ten consecutive trading days. Trading of its securities will be suspended on August 6, 2026, and a Form 25-NSE will be filed. The …
This article provides the "Price to sales forward" data for VSee Health, Inc. (BOATS:VSEEW). It presents a specific financial metric for the company, indicating its valuation based on future sales. The content primarily focuses on this single financial data point without further analysis or …
The article provides a revenue breakdown for VSee Health, Inc. (NASDAQ: VSEEW), highlighting that the United States is its largest revenue contributor. In the last year, the U.S. segment generated $14.62 million USD, an increase from $10.42 million USD the previous year. The data …
VSee Health has secured a $336,000 unsecured convertible promissory note from Labrys, which includes a $36,000 original issue discount and carries a 12% interest charge, maturing on June 30, 2027. The agreement allows for optional prepayment and a proceeds sweep mechanism for repayment. Conversion …
VSee Health has signed a non-binding letter of intent to acquire healthcare technology and operating assets valued at approximately $42 million. This acquisition will bring an integrated healthcare commerce platform with over $35 million in annual revenue and $7 million in EBITDA into VSee's …
VSee Health Inc. (NASDAQ: VSEE) has signed a non-binding letter of intent to acquire a vertically integrated healthcare commerce platform for approximately $42 million. This acquisition is expected to add over $35 million in annualized revenue and about $7 million in EBITDA, significantly expanding …
VSee Health (NASDAQ: VSEE) has entered into a non-binding letter of intent to acquire healthcare technology and operating assets for approximately $42 million. This acquisition is projected to add over $35 million in unaudited annual revenue run rate and about $7 million in EBITDA. …
VSee Health Inc. announced it has entered into a non-binding letter of intent to acquire specific healthcare technology and operating assets. These assets operate an integrated healthcare commerce platform catering to the U.S. clinic-based wellness market, with current unaudited annual run rates exceeding $35 …
VSee Health, Inc. has signed a non-binding letter of intent to acquire certain healthcare technology and operating assets for $42 million. This acquisition is expected to add over $35 million in annualized revenue and approximately $7 million in EBITDA. The transaction aligns with VSee's …
This article provides a technical analysis of Vsee Health Inc (VSEE), focusing on its price momentum, support, resistance levels, and various technical indicators and moving averages. As of July 29, 2026, VSEE has a price momentum score of 5.52, ranking 70th in its industry, …
VSee Health has signed a non-binding letter of intent to acquire specific technology and operating assets that support a healthcare commerce platform. This acquisition aims to serve the US clinic-based wellness sector. The company anticipates that this proposed acquisition could add over $35 million …
VSee Health, Inc. signed a letter of intent to acquire certain healthcare technology and operating assets on July 29, 2026. This acquisition is pending regulatory approval, a due diligence investigation, and a definitive agreement. The company focuses on virtual care solutions through an API-driven …
VSee Health (NASDAQ: VSEE) has entered into a non-binding letter of intent to acquire healthcare technology and operating assets valued at approximately $42 million. These assets, which support a vertically integrated healthcare commerce platform, are reported to have an unaudited annual revenue run rate …
VSee Health, Inc. announced that its Board of Directors has initiated a comprehensive strategic review to maximize shareholder value. The company is in late-stage discussions with potential strategic partners and is evaluating various strategic alternatives, including partnerships, mergers, and acquisitions. CEO Imo Aisiku believes …
This article attempts to provide a revenue breakdown for Vsee Health Inc (VSEE) by business segments and regional contributions. However, it explicitly states that the relevant data have not been disclosed by the company yet. Therefore, the content highlights the lack of available information …
This article details the shareholder structure of Vsee Health Inc (VSEE), listing its major individual and institutional holders. It provides a breakdown of shareholder types, institutional shareholding over several quarters, and recent shareholder activities including changes in holdings for key investors. The stock currently …
This article analyzes the financial health of Vsee Health Inc (VSEE), assigning it a current financial score of 5.49, which ranks it 461 out of 485 in the Software & IT Services industry, indicating a weak financial status and low operating efficiency. The report …
Vsee Health Inc (VSEE) is trading at $0.079, down 2.59%. The company operates through VSee Lab, Inc. and iDoc Virtual Telehealth Solutions, Inc., providing a no-code/low-code SaaS telehealth platform and acute care telehealth services. Key executives and shareholder information, including institutional holdings, are detailed.
VSee Health, Inc. has announced a proposed reverse stock split of up to 80-for-1 to maintain its Nasdaq listing. This decision, which is subject to shareholder and regulatory approval, follows the termination of a previous equity purchase agreement and a reduction from an earlier …
VSee Health, Inc. has reaffirmed its commitment to minimizing shareholder dilution and maintaining its Nasdaq listing. The company announced a proposed maximum 80-for-1 reverse stock split, significantly reduced from a previously considered 250-to-1 ratio, and confirmed the termination of a standby equity purchase agreement. …
VSee Health (NASDAQ:VSEE) announced the termination of its standby equity purchase agreement, eliminating expectations of near-term dilution, and reaffirmed its commitment to minimizing shareholder dilution. The company's board also approved a proposed reverse stock split of up to 80-for-1, down from a previously referenced …
Search by ticker symbol or company name and select a result to open its chart.